Case Reports
Vol. 4 No. 1 (2012): Reviews, Articles, Case Reports and Letters
Systemic granulomatous reaction secondary to treatment of bladder cancer with Bacillus Calmette-Guerin
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: June 18, 2012
21008
Views
603
Downloads
19226
HTML
Hematology,
Infectious Diseases,
Internal Medicine
Authors
Intravesical instillation of Bacillus Calmette-Guérin is the elective treatment for transitional cell and in situ bladder carcinoma. Severe complications occur very seldom, but must be known and promptly recognized. We describe the case of a 48-year-old man, treated with chemo-immunotherapy ten years before for a follicular lymphoma, who developed a systemic granulomatous reaction after his twelfth intravescical BCG instillation for bladder cancer.
Downloads
Download data is not yet available.
Citations
Ethics Approval
Case reportHow to Cite
“Systemic granulomatous reaction secondary to treatment of bladder cancer with Bacillus Calmette-Guerin” (2012) Mediterranean Journal of Hematology and Infectious Diseases, 4(1), p. e2012040. doi:10.4084/mjhid.2012.040.
